Sitagliptin + Metformin

DRUG6 trials

Conditions

Diabete MellitusDiabetesDiabetes MellitusDiabetes Mellitus, Type 2Dyslipidemia in Patients With Diabetes MellitusInsulin ResistanceObesity Type 2 Diabetes MellitusPre-diabetes

Phase 2

Metformin and Sitagliptin in Women With Previous Gestational Diabetes

CompletedNCT01336322

University of PisaPre-diabetes

Start: 2011-05-31End: 2018-12-31Updated: 2019-03-25

Phase 3

Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus

CompletedNCT06952231

University of LahoreDiabetes Mellitus

Start: 2024-05-21End: 2025-01-05Updated: 2025-04-30

Phase 4

Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM

CompletedNCT00820573

The University of Texas Health Science Center at San AntonioDiabetes

Start: 2009-10-31End: 2012-10-31Updated: 2013-12-13

A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes

CompletedNCT01718093

Baylor College of MedicineType 1 Diabetes

Start: 2012-10-31End: 2015-12-31Updated: 2017-04-24

Unknown Phase

Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone

CompletedNCT01332370

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2009-12-31End: 2010-12-31Updated: 2017-06-02

Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes

CompletedNCT07172269

Mais Qais HbeebDiabete Mellitus, Dyslipidemia in Patients With Diabetes Mellitus, Insulin Resistance +2

Start: 2024-09-15End: 2025-05-26Updated: 2025-09-15

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01